Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

2014122 citationsJournal Articlegold Open Access

Authors

This study provides Class I evidence that BIIB033 is well tolerated and safe (serious adverse event rate 0%, 95% confidence interval 0-7.6%).

Good health and well-being

Published in: Neurology Neuroimmunology & Neuroinflammation

Volume 1, Issue 2, pp. e18-e18

Field-Weighted Citation Impact: 13.30